ANPI Angiotech Pharmaceuticals - Common Shares (MM)

Angiotech Pharmaceuticals to participate in Banc of America Conference VANCOUVER, July 21 /PRNewswire-FirstCall/ -- Angiotech Pharmaceuticals, Inc. (NASDAQ:ANPINASDAQ:TSX:NASDAQ:ANP), is scheduled to participate in the Banc of America Securities 2005 Specialty Pharmaceuticals Conference. Dr. William Hunter, President and Chief Executive Officer of Angiotech, will be making a 20-minute presentation at the conference on Thursday, July 28th, 2005 at 11:15 am EST (8:15 am PST). This presentation will not be webcast. Vancouver-based Angiotech Pharmaceuticals, Inc. is a specialty pharmaceutical company pioneering the combination of pharmaceutical compounds with medical devices and biomaterials to both create novel solutions for poorly addressed disease states and dramatically improve surgical outcomes. To find out more about Angiotech Pharmaceuticals, Inc. (NASDAQ:ANPINASDAQ:TSX:NASDAQ:ANP), please visit our website at http://www.angiotech.com/ Company Contacts: Todd Young, Vice President, Investor Relations and Communications (604) 221-7676 ext 6933 Rui Avelar, Senior Vice President, Medical Affairs and Communications (604) 221-7676 ext 6996 Media Relations: Wendy Carhart Waggener Edstrom Bioscience (503) 443-7354 email: DATASOURCE: Angiotech Pharmaceuticals, Inc. CONTACT: Company Contacts: Todd Young, Vice President, Investor Relations and Communications, (604) 221-7676 ext 6933; Rui Avelar, Senior Vice President, Medical Affairs and Communications, (604) 221-7676 ext 6996; Media Relations: Wendy Carhart, Waggener Edstrom Bioscience, (503) 443-7354, email:

Copyright